This resolution supports designating September 2025 as "National Ovarian Cancer Awareness Month." It lists facts from the resolution: ovarian cancer is the fifth-leading cause of cancer death among women. A woman's lifetime risk of being diagnosed is about 1 in 91. The American Cancer Society estimates 20,890 new cases and 12,730 deaths in 2025. The 5-year survival rate is 51.6 percent overall and over 90 percent when diagnosed early. There is no reliable early detection test for ovarian cancer. About 80 percent of cases are detected at an advanced stage. Roughly 20 percent of ovarian cancers are linked to hereditary risk, and some BRCA gene changes can raise risk substantially. The resolution also notes symptom guidance, disparities in outcomes for Black women and other underserved groups, low rates of recommended genetic testing, gaps in research knowledge, and the role of awareness events held each September.
The House is expressing support for naming September 2025 as a month to raise awareness about ovarian cancer. The resolution encourages public and health care provider awareness of common symptoms (for example, bloating, pelvic or abdominal pain, feeling full quickly, and urinary symptoms), the importance of family history and genetic counseling, and the need for more research and education. Community groups and organizations that already hold events in September may use the designation to promote outreach.
No publicly available information.
Supporters say the designation will increase public knowledge of ovarian cancer symptoms and risk factors, highlight gaps in early detection and research, draw attention to disparities in diagnosis and outcomes (including higher mortality for Black women), and encourage genetic counseling and testing where appropriate. The resolution cites statistics, guideline recommendations, and ongoing awareness activities by advocacy organizations as reasons to support the month.
No publicly available information.